Emerson Q4 FY2026 earnings review
Quarter ended September 30, 2026
For information only, not investment advice. No rating or price target.
Adjusted EPS rose 14.8% to $1.86, and FY2027 EPS guidance sits above consensus.
Emerson · Q4 FY2026 · Published Nov 4, 2026 · By DeepCell AI · Sources
Quarter ended September 30, 2026
For information only, not investment advice. No rating or price target.
Built with DeepCell / deepcell.net
1 · Emerson (EMR) Q4 FY2026 earnings review
Note: EBITA is earnings before interest, taxes and amortisation. Underlying growth excludes currency and significant acquisitions and divestitures. The Nov 4 price is intraday, as the US close was not yet available.Source: Emerson Form 8-K, Ex. 99.1, Nov 4, 2026; Zacks and MarketBeat consensus; Yahoo Finance prices, Nov 3–4, 2026
2 · Executive summary
Q4 FY2026 results vs. consensus (Zacks and MarketBeat, Nov 4, 2026)
| Metric | Actual | Consensus | Variance | Result |
|---|---|---|---|---|
| Adjusted EPS (Zacks) | $1.86 | $1.85 | +$0.01 / +0.5% | Beat |
| Net sales (MarketBeat) | $5,201M | $5,110M | +$91M / +1.8% | Beat |
Share price, Nov 3–4, 2026 (Yahoo Finance)
| Emerson (EMR) | Nov 3 close | Nov 4 intraday | Change |
|---|---|---|---|
| EMR ($) | $166.39 | $171.45 | +3.0% |
Nov 4 price at 12:34 PM ET, intraday; base is the Nov 3 close.
Note: Zacks put revenue 1.6% above its estimate, consistent with the MarketBeat figure.Source: Emerson Form 8-K, Ex. 99.1, Nov 4, 2026; Zacks via Yahoo Finance and MarketBeat, Nov 4, 2026; Yahoo Finance prices
3 · Q4 results vs. consensus
FY2027 and Q1 FY2027 guidance vs. consensus (Zacks, Nov 4, 2026)
| Metric | Guidance | Consensus | Variance | vs. Street |
|---|---|---|---|---|
| FY2027 adjusted EPS | $7.25 | $7.21 | +$0.04 / +0.6% | Above |
| FY2027 net sales, implied | $19,931M | $19,880M | +$51M / +0.3% | In line |
| Q1 FY2027 adjusted EPS, midpoint | $1.60 | $1.61 | -$0.01 / -0.6% | Below |
FY2027 company guidance
| Metric | FY2027 | Q1 FY2027 |
|---|---|---|
| Net sales growth, about | 5% | 5% |
| GAAP EPS, about | $5.70 | $1.19 to $1.23 |
| Free cash flow | $3.8B to $3.9B | Not given |
| Share repurchases, about | $2.5B | $1.5B |
Note: Implied net sales apply about 5% growth to FY2026 net sales. Guidance figures are approximate.Source: Emerson Form 8-K, Ex. 99.1, Nov 4, 2026; Zacks consensus via Yahoo Finance, Nov 4, 2026
4 · Guidance vs. consensus
Key figures
| Metric | Q4 FY2025 | Q4 FY2026 | YoY |
|---|---|---|---|
| Net sales | $4.9B | $5.2B | 7.1% |
| Adjusted segment EBITA | $1.3B | $1.5B | 13.4% |
| Pretax earnings | $0.8B | $1.0B | 31.2% |
| Adjusted EPS | $1.62 | $1.86 | 14.8% |
Note: EBITA is earnings before interest, taxes and amortisation. Results are continuing operations. Adjusted figures are Emerson’s non-GAAP measures.Source: Emerson Form 8-K, Ex. 99.1, Nov 4, 2026; analysis of company data
5 · Q4 key financials
Sales and adjusted EBITA by business group
Q4 FY2026
| Business group | Sales | Underlying growth | Adjusted EBITA | Margin |
|---|---|---|---|---|
| Software and Systems | $1,712M | +14% | $553M | 32.3% |
| Intelligent Devices | $2,916M | +4% | $827M | 28.4% |
| Safety and Productivity | $573M | +2% | $131M | 22.9% |
| Total | $5,201M | +7% | $1,511M | 29.1% |
Note: EBITA is earnings before interest, taxes and amortisation. Margin is adjusted EBITA divided by sales.Source: Emerson Form 8-K, Ex. 99.1, Nov 4, 2026; analysis of company data
6 · Segment results
Net sales bridge by business group
$ million, Q4 FY2025 to Q4 FY2026
Note: Steps are each group’s change in reported sales.Source: Emerson Form 8-K, Ex. 99.1, Nov 4, 2026; analysis of company data
7 · Net sales bridge
Sales by business unit
$ million, Q4 FY2026
Note: Control Systems is Control Systems and Software. Safety and Productivity is a single business unit.Source: Emerson Form 8-K, Ex. 99.1, Nov 4, 2026; analysis of company data
8 · Sales by business unit
GAAP EPS to adjusted EPS
$ per diluted share, Q4 FY2026
Note: Other items are acquisition fees, pension mark-to-market, tariff refunds and discrete taxes.Source: Emerson Form 8-K, Ex. 99.1, Nov 4, 2026; analysis of company data
9 · EPS bridge
Note: EBITA is earnings before interest, taxes and amortisation. Margins are divided by net sales. Segment EBITA excludes amortisation and restructuring.Source: Emerson Form 8-K, Ex. 99.1, Nov 4, 2026; analysis of company data
10 · Margin analysis
Operating cash flow to free cash flow
$ million, Q4 FY2026
Note: FCF is operating cash flow less capital expenditures.Source: Emerson Form 8-K, Ex. 99.1, Nov 4, 2026; analysis of company data
11 · Free cash flow
Note: Regional growth is as reported in Table 4 of the release.Source: Emerson Form 8-K, Ex. 99.1, Nov 4, 2026; analysis of company data
12 · Sales by region
Note: Net debt is short-term borrowings, current maturities and long-term debt, less cash and equivalents.Source: Emerson Form 8-K, Ex. 99.1, Nov 4, 2026; analysis of company data
13 · Balance sheet and net debt
Note: These are analytical watch points, not company targets.Source: Emerson Form 8-K, Ex. 99.1, Nov 4, 2026; analysis of company data
14 · Key risks to guidance
| Claim | Evidence | Calculation |
|---|---|---|
| Net sales rose | 5.4% to $19.0B | Table 1 |
| Underlying sales growth | 4% | Table 7 |
| Adjusted EPS rose | 9.7% to $6.59 | Table 6 |
| GAAP EPS | $4.79 | Continuing operations |
| Adjusted segment EBITA margin | 28.2% | Segment EBITA over net sales |
| Free cash flow rose | 8.9% to $3.5B | Table 7 |
EBITA is earnings before interest, taxes and amortisation. Source: Emerson Form 8-K, Ex. 99.1, Nov 4, 2026; analysis of company data
15 · Appendix: Full year FY2026
| Claim | Evidence | Calculation |
|---|---|---|
| Software and Systems margin | 27.5% to 32.3% | Adjusted EBITA over sales |
| Intelligent Devices margin | 28.4% to 28.4% | Adjusted EBITA over sales |
| Safety and Productivity margin | 22.6% to 22.9% | Adjusted EBITA over sales |
| Software and Systems share of sales | 31.0% to 32.9% | Mix shift |
| Adjusted EBITA margin | 26.1% to 27.1% | Includes corporate items |
| Gross margin | 51.9% to 52.7% | Net sales less cost of sales |
EBITA is earnings before interest, taxes and amortisation. Source: Emerson Form 8-K, Ex. 99.1, Nov 4, 2026; analysis of company data
16 · Appendix: Segment margins
| Claim | Evidence | Calculation |
|---|---|---|
| Dividends paid, FY2026 | $1.2B | Table 3 |
| Share repurchases, FY2026 | $1.0B | Table 3 |
| Returns as share of FY2026 FCF | 63% | Dividends plus buybacks over FCF |
| New quarterly dividend | $0.595 per share, up 7% | Payable Dec 10, 2026 |
| FY2027 planned capital return | About $3.8B | Buybacks plus dividends |
| Diluted shares | 565.5M to 559.7M | Q4 average |
FCF is free cash flow. Source: Emerson Form 8-K, Ex. 99.1, Nov 4, 2026; analysis of company data
17 · Appendix: Capital returns
| Claim | Evidence | Calculation |
|---|---|---|
| Adjusted EPS growth implied | 10.0% | About $7.25 over FY2026 adjusted EPS |
| Free cash flow midpoint | $3.9B, up 8.9% | Midpoint over FY2026 FCF |
| Operating cash flow | $4.3B to $4.4B | Company guidance |
| Underlying sales growth | About 5% | Company guidance |
| Q1 FY2027 adjusted EPS | $1.58 to $1.62 | Company guidance |
| Dividends planned | About $1.3B | Company guidance |
Source: Emerson Form 8-K, Ex. 99.1, Nov 4, 2026; analysis of company data
18 · Appendix: Guidance math
Income statement
| $ million | Q4 FY2025 | Q4 FY2026 |
|---|---|---|
| Net sales | $4,855M | $5,201M |
| Cost of sales | $2,335M | $2,461M |
| SG&A expenses | $1,330M | $1,393M |
| Pretax earnings | $760M | $997M |
GAAP EPS to adjusted
| $ per share | Q4 FY2025 | Q4 FY2026 |
|---|---|---|
| GAAP EPS | $1.07 | $1.33 |
| Amortisation and restructuring | $0.35 / $0.11 | $0.34 / $0.14 |
| Other items | $0.09 | $0.05 |
| Adjusted EPS | $1.62 | $1.86 |
Note: Results are continuing operations. Adjusted EPS follows Emerson’s Table 6 definition.Source: Emerson Form 8-K, Ex. 99.1, Nov 4, 2026; analysis of company data
19 · Appendix: Income statement
Built with DeepCell / deepcell.net
20 · Sources
For information only. This presentation is provided for information only. It is not investment, legal, tax or accounting advice, and it is not an offer, or a solicitation of an offer, to buy or sell any security.
No recommendation. It carries no rating, price target or buy, sell or hold view, and it was prepared without regard to any reader's investment objectives, financial situation or needs.
Sources and accuracy. Company figures come from Emerson's Form 8-K of November 4, 2026 (Exhibit 99.1). Consensus estimates (Zacks, MarketBeat) and share prices (Yahoo Finance) are third-party data, credited on the sources page. We have not independently verified third-party data.
Basis of presentation. Figures are US GAAP continuing operations for the quarters ended September 30, 2026 and 2025, in US dollars. Emerson's fiscal year ends September 30.
Forward-looking statements. Company guidance, consensus estimates and the watch items in this deck are forward-looking. They rest on assumptions that may prove wrong, and actual results may differ materially.
Non-GAAP measures. Adjusted EPS, adjusted EBITA, adjusted segment EBITA, underlying sales and free cash flow follow Emerson's own definitions and are reconciled in its release. They may not be comparable with other companies' measures.
No liability. No liability is accepted for any direct or indirect loss arising from the use of this presentation or its contents.
No affiliation. This presentation is not affiliated with, reviewed or endorsed by Emerson Electric Co. Company names belong to their owners.
How it was made. The deck was built with DeepCell, with figures linked to a model in the file. Readers should check the figures against the original filings.
Date of analysis. The analysis reflects information available on November 4, 2026, before the US market close.
Built with DeepCell / deepcell.net
21 · Disclosures
Not investment advice; no rating or price target.
Built in DeepCell Every figure on these slides opens its formula and its source. See how a review like this is made.
Send the link: it opens with the picture below, and every number on the page still opens its formula and source. The picture is free to download and share.
Wayfair · Q3 2026
Revenue rose 9.7% and adjusted EPS beat LSEG by 17.7%, a clear beat.
Nov 4, 202621 slides
Novo Nordisk · Q3 2026
Adjusted operating profit rose 33.9% and beat estimates, and Novo raised its 2026 guidance.
Nov 4, 202621 slides
McDonald's · Q3 2026
Q3 adjusted EPS beat LSEG consensus by 5.6% and revenues missed it, while shares rose 4.7% intraday.
Nov 4, 202621 slides
Datadog · Q3 2026
Revenue rose 35.2% and beat consensus by 5.0%, but the Q4 revenue guide is flat.
Nov 4, 202621 slides
CVS Health (CVS) · Q3 2026
Adjusted EPS of $2.09 beat the Zacks consensus by 29.0%, and CVS raised its 2026 outlook.
Nov 4, 202621 slides